SlideShare a Scribd company logo
Dr. Vishal Golay
Basic terminology
• pH – signifies free hydrogen ion concentration. pH is inversely
  related to H+ ion concentration.
• Acid – a substance that can donate H+ ion, i.e. lowers pH.
• Base – a substance that can accept H+ ion, i.e. raises pH.
• Anion – an ion with negative charge.
• Cation – an ion with positive charge.
• Acidemia – blood pH< 7.35 with increased H+ concentration.
• Alkalemia – blood pH>7.45 with decreased H+ concentration.
• Acidosis – Abnormal process or disease which reduces pH due to
  increase in acid or decrease in alkali.
• Alkalosis – Abnormal process or disease which increases pH due to
  decrease in acid or increase in alkali.
Daily production ~ 1 mEq of H+/kg/day

   Sulfuric acid ( from sulphur containing AA)
   Organic acids (from intermediary metabolism)
   Phosphoric acid ( hydrolysis of PO4 containing proteins)
   Hydrochloric acid (from metabolism of cationic AA-
    Lysine, Arginine, Histidine)
pH in humans is tightly regulated between 7.35-
                      7.45.



                           Chemical
                            Buffers




             Respiratory
             regulatory
              responses


                                Renal regulatory
                                   responses
   Buffers are chemical systems which either release or
    accept H+ and minimize change in pH induced by an
    acid or base load.

   First line of defense blunting the changes in [H+]


        A buffer pair consists of:
    A base (H+ acceptor) & an acid (H+ donor)
Buffers continued……



Extracellular buffers:      Intracellular buffers:
                            •Hemoglobin
                      Examples:
                            •Proteins
• HCO3¯/H2CO3
                HPO42- + (H+•Organophosphate
                            )↔H2 PO4-
• HPO4²¯/H2PO4¯               compounds
• Protein buffersCO2 ↔H2 CO3 ↔H+ + HCO3-
          H2 O +            •Bone apatite
   2nd line of defense

   10-12 mol/day CO2 is accumulated and is
    transported to the lungs as Hb-generated HCO3 and
    Hb-bound carbamino compounds where it is freely
    excreted.
          H2 O + CO2 ↔H2 CO3 ↔H+ + HCO3-

   Accumulation/loss of CO2 changes pH within
    minutes
   Balance affected by neurorespiratory control of
    ventilation.

   During Acidosis, chemoreceptors sense ↓pH and
    trigger ventilation decreasing pCO2.

   Response to alkalosis is biphasic. Initial
    hyperventilation to remove excess pCO2
    followed by suppression to increase pCO2 to
    return pH to normal
   Kidneys are the ultimate defense against the
    addition of non-volatile acid/alkali.

            HA + NaHCO3↔H2 O + CO2 + NaA
           Addition of Acid causes loss of HCO3¯

   Kidneys play a role in the maintenance of this HCO3¯
    by:
     Conservation of filtered HCO3 ¯
     Regeneration of HCO3 ¯
   Kidneys balance nonvolatile acid generation
    during metabolism by excreting acid.

   Each mEq of NAE corresponds to 1 mEq of
    HCO3¯ returned to ECF.

   NAE has three components:
    1. NH4⁺ .
    2. Titrable acids (acid excreted that has titrated urinary
       buffers)
    3. Bicarbonate.
                                 NAE= NH4⁺ + TA-
                                     HCO3¯
Acid base and control for the dialysis technician
Generally a metabolic acidosis develops due to:
1. Failure of NAE to match with the endogenous acid
   production.
2. Failure to recapture filtered HCO3-

There is an absence of renal compensation in ESRD
   making interpretation simpler.
In addition to CKD per se:
 DKA                       GI alkali loss
 Alcoholic ketoacidosis    Hemofiltration with NaCl
 Lactic acidosis            replacement
 Toxin ingestion           Ammonium chloride
 Catabolic state            ingestion
 High protein intake
 Large salt and water
   intake between dialysis
 Vomiting
 Nasogastric drainage
 Exogenous alkali supplementation (NaHCO3,
  KHCO3, CaCO3, Lactate, Acetate, Citrate,
  Glutamate, Propionate)
 Alumimium hydroxide + Na Polysterine sulfonate
  coadministration
   Respiratory acidosis-hypoventilation
   Respiratory alkalosis-hyperventilation

    It is important to remember that respiratory acid-
            base disorders are dangerous in ESRD
             as there is no renal compensation.
Laboratory evaluation in patients with ESRD
   should include not only HCO3 measurement but
                  also pH and CO2.

Example:
    Even with a HCO3¯ in the normal range, the
    patient maybe having a dangerously high pH and
    low PCO2 due to respiratory alkalosis.
Metabolic acidosis:
 Initially hyperchloremic but becomes high AG as
  ESRD sets in.
 Associated with:
   Insulin resistance
   GH/IGF-1 axis suppression
   Mineral bone disease
   Protein degradation and muscle wasting
   Increase risk of mortality
   ITT studies show delay in progression of CKD with Rx
Metabolic alkalosis:
   Nausea, lethargy and headache
   Soft tissue calcification
   Cardiac arrhythmia
   Sudden death
   Reflection of a low protein intake in dialysis patients.
   Poses risk for dangerous alkalosis with minimal
    hyperventilation.
Respiratory alkalosis:
   Dizziness, confusion, seizures (if acute).
   Cardiovascular compromise (specially if ventilated).
   Reflects underlying diseases which have a poor outcome.


Respiratory acidosis:
   Anxiety, dyspnea, confusion, hallucinations, coma.
   Sleep disturbances, loss of memory, daytime
    sleepiness, tremor, myoclonus, asterixis.

Poor compensation may cause dramatic changes in Ph
   Correction is by adding HCO3- instead of the removal
    of H+.

   This regulation is un-physiologic and determined by
    the physical principles of diffusion and convection.

               Gain of HCO3- in dialysis is determined by the
                transmembrane concentration gradient


Dialysis prescription (fixed)   Endogenous acid production (variable)
Acid base and control for the dialysis technician
1950’s-1960’s:
 HCO3¯ was the alkali source.
 Initially 26mM/L→ later 35mM/L
 pH was adjusted to 7.4 to prevent CaCO3 ppt. by
  aeration with CO2/O2 gas mixture.
 Central solution preparation was not possible.
1960’s -1980’s:
     Acetate became the chief alkali used.
     Aim was to create a positive balance of acetate (3-4mM/L)
      which is later metabolized to HCO3¯.
     A value of 37mEq/L was set by trial and error.
     It was inefficient (avg. predialysis HCO3¯ was <18mM/L)
      and needed large acetate levels which accumulated as
      dialysis became more efficient

   Toxicity: hypotension, CO2 loss (decreased ventilatory
    drive and hypoxemia).
   Proportioning systems enabled use of HCO3¯.
   Acetic acid in the “acid concentrate” reacted with
    HCO3¯ to generate acetate which prevented a rapid
    rise of pH.

   Thus the final dialysis solution composition
    became:
     HCO3¯ =30-40mM/L
     Acetate=2-4mM/L
     pH=7.1-7.3
   This raised the avg. predialysis HCO3¯ by 3-4mM/L
   Sorbent cartridge hemodialysis.
   Hemofiltration.
   Acetate-free biofiltration.
Dialysiance of
           HCO3¯


Transmemb. HCO3¯ gradient over time
   Postdialysis HCO3¯ :
     Determined by the dialysis prescription.
   Predialysis HCO3¯ :
     Endogenous acid production between Rx (diet, catabolic
      state)-This may cause variations as large as 6mEq/L
     Rate of fluid retention-”dilution acidosis” . 1 L ot fluid
      retained can affect preHD HCO3¯ by >1mEq/L.

    The avg. preHD HCO3¯ values in stable patients on
    3/wk HD is 19-25mEq/L.
 Target for a preHD HCO3¯ of >22mEq/L (following
  the KDIGO-CKD 2012 guidelines).
 Some reasonable targets are:
     Intradialytic gain of 6-10mM/L of HCO3¯
     Target post HD HCO3¯ of 30-34mM/L (risky in some) using
    a higher bath HCO3 of ~36-40mM/L
   A more reasonable target would be a post-HD HCO
Always look for causes if target not achieved 3¯ of
    approx. 27mM/L once acidosis is controlled.
(eg. nutrition, fluid intake, RRF with loss of HCO3¯, loss
   Only definite way is to measure pre and post HD HCO3¯
in stool etc.)
    levels.
Daily hemodialysis (nocturnal HD or short daily HD):

   These modalities quickly normalizes HCO3¯.
   Pre and post HD variations can be <1mM/L.
   Thus, a lower bath HCO3¯ of 28-32mM/ should be
    used.
Critical care settings:
   Always evaluate the acid-base status before HD.
   They are high risk for alkalosis.
   If the pre HD HCO3¯ is >28mM/L or there is respiratory
    alkalosis, use a bath with lower HCO3 (eg. 20-28mM)
   Respiratory alkalosis=normalize pH and not HCO3¯.
   Severe preHD metabolic acidosis (HCO3¯ <10mM/L): excess
    correction can paradoxically cause CSF acidification and
    lactic acidosis).
Kussmaul’s respiration (deep and rapid)


Cheyne-Stokes respiration
•Brain injury
•CO poisoning
•Metabolic encephalopathy

Biot’s breathing
•Medullary injury
•Chronic opioid use


Apneustic respiration
•Damage to upper pons

Ataxic respiration
•Damage to the medulla oblongata
THANK YOU

More Related Content

PPT
Water treatment and quality control of dialysate.
PDF
Water treatment
PPTX
Dialysis prescription
PPTX
Product water and hemodialysis dialysis solution
PPT
Dialysis dose prescription (the basics) dr ujjawal
PPT
DIALYSIS WATER TREATMENT
PPTX
Product water and hemodialysis dialysis solution
PPTX
History of dialysis
Water treatment and quality control of dialysate.
Water treatment
Dialysis prescription
Product water and hemodialysis dialysis solution
Dialysis dose prescription (the basics) dr ujjawal
DIALYSIS WATER TREATMENT
Product water and hemodialysis dialysis solution
History of dialysis

What's hot (20)

PPTX
Anticoagulation in hemodialysis
PPTX
Volume status and fluid overload in peritoneal dialysis
PPTX
Adequacy of haemodialysis
PPTX
Adequacy of Hemodialysis
DOCX
Dialysis Water Treatment
PPTX
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
PDF
Crrt indications and modalities [autosaved]
PDF
Adequacy hd
PDF
Hyertension in patients on regular hemodialysis
PPTX
DIALYZER REUSE , Dialysis prescription.pptx
PPSX
DIALYSIS IN PREGNANCY.ppsx
PPTX
Anticoagulation
PPTX
hemodialysis water treatment.pptx
PPTX
HEMODIALYSIS EMERGENCIES
PPTX
Advancing Dialysis Hypertension in Dialysis Patients
PPTX
high-flux.pptx
PPTX
priming.pptx
PPTX
Dry weight management mansoura 2017
PPTX
HD machine
PPTX
Anticoagulation in hemodialysis
Anticoagulation in hemodialysis
Volume status and fluid overload in peritoneal dialysis
Adequacy of haemodialysis
Adequacy of Hemodialysis
Dialysis Water Treatment
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Crrt indications and modalities [autosaved]
Adequacy hd
Hyertension in patients on regular hemodialysis
DIALYZER REUSE , Dialysis prescription.pptx
DIALYSIS IN PREGNANCY.ppsx
Anticoagulation
hemodialysis water treatment.pptx
HEMODIALYSIS EMERGENCIES
Advancing Dialysis Hypertension in Dialysis Patients
high-flux.pptx
priming.pptx
Dry weight management mansoura 2017
HD machine
Anticoagulation in hemodialysis
Ad

Viewers also liked (20)

PPTX
synthetic food colours
PPT
Electric field and Electroplating
PPTX
Food dye presentation
DOCX
Electrochemistry
PPT
electroplating
PPTX
Synthetic Food coloring
PPTX
Electroplating
PPTX
Food colours
PPTX
Electroplating!
PPTX
Food Coloring
PPTX
Factors affecting electrolysis
PPTX
Industrial metallurgy
PPTX
Power point presentation based on electroplating
PPTX
Electrochemistry
PDF
Zinc and zinc alloy plating
PPT
Dye classification .
PPT
Chapter 6 electrochemistry
PPT
Analytical chemistry
PPT
Food additives ppt
PPTX
Introduction to dyes
synthetic food colours
Electric field and Electroplating
Food dye presentation
Electrochemistry
electroplating
Synthetic Food coloring
Electroplating
Food colours
Electroplating!
Food Coloring
Factors affecting electrolysis
Industrial metallurgy
Power point presentation based on electroplating
Electrochemistry
Zinc and zinc alloy plating
Dye classification .
Chapter 6 electrochemistry
Analytical chemistry
Food additives ppt
Introduction to dyes
Ad

Similar to Acid base and control for the dialysis technician (20)

PDF
Acid Base Disorders
PPTX
Acid base disorders
PDF
Approach to Acid-Base Disturbances & Renal Tubular Acidosis (RTA)
PPTX
Metbolic acidosis and alkalosis
PPTX
ACID BASE DISORDERS
PPTX
Acid base balance sharath
PPTX
Metabolic acidosis and alkalosis ppt.pptx
PDF
PPTX
Principles of Acid-Base Imbalance
PPT
ABB.ppt
PPTX
ABG (Emergency Medicine)
PDF
CH 7.pdf acide base disorders...........
PPT
4Acid Base Disturbances.ppt
PPTX
Pathophysiology of ph
PPTX
ACID BASE management, base deficit correction
PPTX
acidbasebalancesimplified.pptx
PPTX
Acid base balance-2
PPTX
ACID BASE DISORDERS 2.pptx
PPTX
Blood gas analysis.pptx
PPTX
Acid Base Disturbances and pathological conditions
Acid Base Disorders
Acid base disorders
Approach to Acid-Base Disturbances & Renal Tubular Acidosis (RTA)
Metbolic acidosis and alkalosis
ACID BASE DISORDERS
Acid base balance sharath
Metabolic acidosis and alkalosis ppt.pptx
Principles of Acid-Base Imbalance
ABB.ppt
ABG (Emergency Medicine)
CH 7.pdf acide base disorders...........
4Acid Base Disturbances.ppt
Pathophysiology of ph
ACID BASE management, base deficit correction
acidbasebalancesimplified.pptx
Acid base balance-2
ACID BASE DISORDERS 2.pptx
Blood gas analysis.pptx
Acid Base Disturbances and pathological conditions

More from Vishal Golay (20)

PPTX
Deceased donor kidney transplantation-Recipient care.
PPT
Approach to deceased donor transplantation
PPTX
SLE: present guidelines and consensus
PPTX
Basics of peritoneal dialysis
PPTX
Bk virus nephropathy
PPTX
Year in review 2011-Nature reviews
PPTX
Membranous nephropathy
PPTX
Contrast induced acute kidney injury
PPTX
Interpretation of the Arterial Blood Gas analysis
PPTX
PRCA post renal transplant-a case and review
PPTX
Diuretics in CKD
PPTX
Transplantation in sensitized patients(seminar)
PPTX
Anemia in Chronic Kidney DIsease
PPTX
Nephrocalcinosis
PPT
PPT
20 sep 2010 siadh
PPTX
Seminar on renal tuberculosis
PPTX
Induction agents in renal transplantation
PPTX
Dialysis statistics(Jan-April'11)
PPT
Renal biopsy seminar
Deceased donor kidney transplantation-Recipient care.
Approach to deceased donor transplantation
SLE: present guidelines and consensus
Basics of peritoneal dialysis
Bk virus nephropathy
Year in review 2011-Nature reviews
Membranous nephropathy
Contrast induced acute kidney injury
Interpretation of the Arterial Blood Gas analysis
PRCA post renal transplant-a case and review
Diuretics in CKD
Transplantation in sensitized patients(seminar)
Anemia in Chronic Kidney DIsease
Nephrocalcinosis
20 sep 2010 siadh
Seminar on renal tuberculosis
Induction agents in renal transplantation
Dialysis statistics(Jan-April'11)
Renal biopsy seminar

Recently uploaded (20)

PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
History and examination of abdomen, & pelvis .pptx
PPT
Obstructive sleep apnea in orthodontics treatment
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
Important Obstetric Emergency that must be recognised
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
DOCX
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
PPTX
Uterus anatomy embryology, and clinical aspects
PPTX
Note on Abortion.pptx for the student note
PPTX
Fundamentals of human energy transfer .pptx
PPTX
SKIN Anatomy and physiology and associated diseases
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
MENTAL HEALTH - NOTES.ppt for nursing students
History and examination of abdomen, & pelvis .pptx
Obstructive sleep apnea in orthodontics treatment
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
ASRH Presentation for students and teachers 2770633.ppt
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
Medical Evidence in the Criminal Justice Delivery System in.pdf
Important Obstetric Emergency that must be recognised
surgery guide for USMLE step 2-part 1.pptx
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
NEET PG 2025 | Pharmacology Recall: 20 High-Yield Questions Simplified
Uterus anatomy embryology, and clinical aspects
Note on Abortion.pptx for the student note
Fundamentals of human energy transfer .pptx
SKIN Anatomy and physiology and associated diseases
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...

Acid base and control for the dialysis technician

  • 2. Basic terminology • pH – signifies free hydrogen ion concentration. pH is inversely related to H+ ion concentration. • Acid – a substance that can donate H+ ion, i.e. lowers pH. • Base – a substance that can accept H+ ion, i.e. raises pH. • Anion – an ion with negative charge. • Cation – an ion with positive charge. • Acidemia – blood pH< 7.35 with increased H+ concentration. • Alkalemia – blood pH>7.45 with decreased H+ concentration. • Acidosis – Abnormal process or disease which reduces pH due to increase in acid or decrease in alkali. • Alkalosis – Abnormal process or disease which increases pH due to decrease in acid or increase in alkali.
  • 3. Daily production ~ 1 mEq of H+/kg/day  Sulfuric acid ( from sulphur containing AA)  Organic acids (from intermediary metabolism)  Phosphoric acid ( hydrolysis of PO4 containing proteins)  Hydrochloric acid (from metabolism of cationic AA- Lysine, Arginine, Histidine)
  • 4. pH in humans is tightly regulated between 7.35- 7.45. Chemical Buffers Respiratory regulatory responses Renal regulatory responses
  • 5. Buffers are chemical systems which either release or accept H+ and minimize change in pH induced by an acid or base load.  First line of defense blunting the changes in [H+] A buffer pair consists of: A base (H+ acceptor) & an acid (H+ donor)
  • 6. Buffers continued…… Extracellular buffers: Intracellular buffers: •Hemoglobin Examples: •Proteins • HCO3¯/H2CO3 HPO42- + (H+•Organophosphate )↔H2 PO4- • HPO4²¯/H2PO4¯ compounds • Protein buffersCO2 ↔H2 CO3 ↔H+ + HCO3- H2 O + •Bone apatite
  • 7. 2nd line of defense  10-12 mol/day CO2 is accumulated and is transported to the lungs as Hb-generated HCO3 and Hb-bound carbamino compounds where it is freely excreted. H2 O + CO2 ↔H2 CO3 ↔H+ + HCO3-  Accumulation/loss of CO2 changes pH within minutes
  • 8. Balance affected by neurorespiratory control of ventilation.  During Acidosis, chemoreceptors sense ↓pH and trigger ventilation decreasing pCO2.  Response to alkalosis is biphasic. Initial hyperventilation to remove excess pCO2 followed by suppression to increase pCO2 to return pH to normal
  • 9. Kidneys are the ultimate defense against the addition of non-volatile acid/alkali. HA + NaHCO3↔H2 O + CO2 + NaA Addition of Acid causes loss of HCO3¯  Kidneys play a role in the maintenance of this HCO3¯ by:  Conservation of filtered HCO3 ¯  Regeneration of HCO3 ¯
  • 10. Kidneys balance nonvolatile acid generation during metabolism by excreting acid.  Each mEq of NAE corresponds to 1 mEq of HCO3¯ returned to ECF.  NAE has three components: 1. NH4⁺ . 2. Titrable acids (acid excreted that has titrated urinary buffers) 3. Bicarbonate. NAE= NH4⁺ + TA- HCO3¯
  • 12. Generally a metabolic acidosis develops due to: 1. Failure of NAE to match with the endogenous acid production. 2. Failure to recapture filtered HCO3- There is an absence of renal compensation in ESRD making interpretation simpler.
  • 13. In addition to CKD per se:  DKA  GI alkali loss  Alcoholic ketoacidosis  Hemofiltration with NaCl  Lactic acidosis replacement  Toxin ingestion  Ammonium chloride  Catabolic state ingestion  High protein intake  Large salt and water intake between dialysis
  • 14.  Vomiting  Nasogastric drainage  Exogenous alkali supplementation (NaHCO3, KHCO3, CaCO3, Lactate, Acetate, Citrate, Glutamate, Propionate)  Alumimium hydroxide + Na Polysterine sulfonate coadministration
  • 15. Respiratory acidosis-hypoventilation  Respiratory alkalosis-hyperventilation It is important to remember that respiratory acid- base disorders are dangerous in ESRD as there is no renal compensation.
  • 16. Laboratory evaluation in patients with ESRD should include not only HCO3 measurement but also pH and CO2. Example: Even with a HCO3¯ in the normal range, the patient maybe having a dangerously high pH and low PCO2 due to respiratory alkalosis.
  • 17. Metabolic acidosis:  Initially hyperchloremic but becomes high AG as ESRD sets in.  Associated with:  Insulin resistance  GH/IGF-1 axis suppression  Mineral bone disease  Protein degradation and muscle wasting  Increase risk of mortality  ITT studies show delay in progression of CKD with Rx
  • 18. Metabolic alkalosis:  Nausea, lethargy and headache  Soft tissue calcification  Cardiac arrhythmia  Sudden death  Reflection of a low protein intake in dialysis patients.  Poses risk for dangerous alkalosis with minimal hyperventilation.
  • 19. Respiratory alkalosis:  Dizziness, confusion, seizures (if acute).  Cardiovascular compromise (specially if ventilated).  Reflects underlying diseases which have a poor outcome. Respiratory acidosis:  Anxiety, dyspnea, confusion, hallucinations, coma.  Sleep disturbances, loss of memory, daytime sleepiness, tremor, myoclonus, asterixis. Poor compensation may cause dramatic changes in Ph
  • 20. Correction is by adding HCO3- instead of the removal of H+.  This regulation is un-physiologic and determined by the physical principles of diffusion and convection. Gain of HCO3- in dialysis is determined by the transmembrane concentration gradient Dialysis prescription (fixed) Endogenous acid production (variable)
  • 22. 1950’s-1960’s:  HCO3¯ was the alkali source.  Initially 26mM/L→ later 35mM/L  pH was adjusted to 7.4 to prevent CaCO3 ppt. by aeration with CO2/O2 gas mixture.  Central solution preparation was not possible.
  • 23. 1960’s -1980’s:  Acetate became the chief alkali used.  Aim was to create a positive balance of acetate (3-4mM/L) which is later metabolized to HCO3¯.  A value of 37mEq/L was set by trial and error.  It was inefficient (avg. predialysis HCO3¯ was <18mM/L) and needed large acetate levels which accumulated as dialysis became more efficient  Toxicity: hypotension, CO2 loss (decreased ventilatory drive and hypoxemia).
  • 24. Proportioning systems enabled use of HCO3¯.  Acetic acid in the “acid concentrate” reacted with HCO3¯ to generate acetate which prevented a rapid rise of pH.  Thus the final dialysis solution composition became:  HCO3¯ =30-40mM/L  Acetate=2-4mM/L  pH=7.1-7.3  This raised the avg. predialysis HCO3¯ by 3-4mM/L
  • 25. Sorbent cartridge hemodialysis.  Hemofiltration.  Acetate-free biofiltration.
  • 26. Dialysiance of HCO3¯ Transmemb. HCO3¯ gradient over time
  • 27. Postdialysis HCO3¯ :  Determined by the dialysis prescription.  Predialysis HCO3¯ :  Endogenous acid production between Rx (diet, catabolic state)-This may cause variations as large as 6mEq/L  Rate of fluid retention-”dilution acidosis” . 1 L ot fluid retained can affect preHD HCO3¯ by >1mEq/L. The avg. preHD HCO3¯ values in stable patients on 3/wk HD is 19-25mEq/L.
  • 28.  Target for a preHD HCO3¯ of >22mEq/L (following the KDIGO-CKD 2012 guidelines).  Some reasonable targets are:  Intradialytic gain of 6-10mM/L of HCO3¯  Target post HD HCO3¯ of 30-34mM/L (risky in some) using a higher bath HCO3 of ~36-40mM/L  A more reasonable target would be a post-HD HCO Always look for causes if target not achieved 3¯ of approx. 27mM/L once acidosis is controlled. (eg. nutrition, fluid intake, RRF with loss of HCO3¯, loss  Only definite way is to measure pre and post HD HCO3¯ in stool etc.) levels.
  • 29. Daily hemodialysis (nocturnal HD or short daily HD):  These modalities quickly normalizes HCO3¯.  Pre and post HD variations can be <1mM/L.  Thus, a lower bath HCO3¯ of 28-32mM/ should be used.
  • 30. Critical care settings:  Always evaluate the acid-base status before HD.  They are high risk for alkalosis.  If the pre HD HCO3¯ is >28mM/L or there is respiratory alkalosis, use a bath with lower HCO3 (eg. 20-28mM)  Respiratory alkalosis=normalize pH and not HCO3¯.  Severe preHD metabolic acidosis (HCO3¯ <10mM/L): excess correction can paradoxically cause CSF acidification and lactic acidosis).
  • 31. Kussmaul’s respiration (deep and rapid) Cheyne-Stokes respiration •Brain injury •CO poisoning •Metabolic encephalopathy Biot’s breathing •Medullary injury •Chronic opioid use Apneustic respiration •Damage to upper pons Ataxic respiration •Damage to the medulla oblongata

Editor's Notes

  • #11: Ammonia contributes 60%, TA contributes 40 % and HCO3 excretion is almost zero under basal conditions.
  • #13: Eg. Low HCO3 in ESRD must always be due to met acidosis as respiratory alkalosis cant explain it. Similarly a high HCO3 can only be due to a metabolic alkalosis as a Resp acidosis cant cause this.
  • #14: “dilution acidosis”. Neither volume addition nor protein catabolism can cause severe acidosis. If HCO3 falls by more than 6-8 acutely=organic acidosis. RTA need not be considered in ESRD.
  • #15: There is on concept of Cl resistant and Cl sensitive metabolic acidosis in ESRD.
  • #18: MBD and muscle metabolism: RCT showed that adverse effects if HCO3 less than 19. Similarly 10-15% increase mortality if HCO3 less than 19.
  • #21: Standard dialysis solution used contains 35-38mM of HCO3.
  • #22: There is a variation due to the intermittent nature of Rx. Thus it is imp to note when the HCO3 is measured. By convention it is the predialysis value that is measured.
  • #24: Acetate was immediately metabolised and only after the metab of the residual acetate after dialysis did the HCO3 rise in blood. Toxicity: vasodlation and hypotension.
  • #26: Uses a sorbent cart which absorbs ammonium ions and replaces H+ which reacts with CO3 to generate HCO3 however, this is not enough and acetate was needed (50-50%0 and caused wide fluctuations.
  • #27: Organic anions are later metabolised liberating HCO3 and adding to the pool.
  • #31: This pH control can be seen even at a much lower HCO3 levels. Lactic acidosis by activating PFK